Hale Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $54.7K

  • Investors
  • 28

Hale Therapeutics General Information

Description

Developer of a vaporizer system designed to help people battling tobacco addiction. The company's system is designed with a comfortable mouthpiece, two-sided grips for comfort, a light-emitting diode indicator for battery life, and companion applications to track usage and wean off the substance to reduce withdrawal symptoms, enabling users to easily reduce their nicotine intake.

Contact Information

Website
www.tryhale.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Application Software
Corporate Office
  • 2025 Washington Avenue
  • Suite 216
  • Philadelphia, PA 19146
  • United States
+1 (609) 000-0000

Hale Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hale Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 09-Jan-2023 $54.7K 00.000 Completed Generating Revenue
11. Accelerator/Incubator 00.000 Completed Generating Revenue
10. Equity Crowdfunding 13-Jul-2022 000.00 00.000 Completed Generating Revenue
9. Accelerator/Incubator 06-Dec-2021 00.000 Completed Generating Revenue
8. Early Stage VC 10-Nov-2021 00.000 Completed Generating Revenue
7. Accelerator/Incubator 04-Nov-2021 00.000 Completed Generating Revenue
6. Early Stage VC (Series 1) 01-Dec-2020 00.000 Completed Generating Revenue
5. Grant 24-Jun-2020 0000 00.000 Completed Generating Revenue
4. Early Stage VC 13-Nov-2019 $1.7M $2.33M 000 Completed Generating Revenue
3. Accelerator/Incubator 01-Apr-2019 $500K $625K Completed Generating Revenue
To view Hale Therapeutics’s complete valuation and funding history, request access »

Hale Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a vaporizer system designed to help people battling tobacco addiction. The company's system is designed wit
Therapeutic Devices
Philadelphia, PA
16 As of 2023
00.000
0000000000 00.000

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
000000000000000000 0
New York, NY
000 As of 0000
00000
00000 0000-00-00
00000000000 00000

0000 (

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut la
0000 00000000
Las Vegas, NV
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hale Therapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pelago Venture Capital-Backed New York, NY 000 00000 00000000000 00000
Lucy (Food Products) Venture Capital-Backed Las Vegas, NV 00 000.00 00000000000 000.00
Glaxosmithkline Consumer Healthcare Corporate Backed or Acquired Gurugram, India 0000 000000&0
Johnson & Johnson Corporation New Brunswick, NJ 000000 0000 000000000 0000
Pfizer (Pharmaceuticals) Corporation New York, NY 00000 000.00 0000 000.00
You’re viewing 5 of 5 competitors. Get the full list »

Hale Therapeutics Patents

Hale Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230172280-A1 Vaporization device Pending 07-Dec-2021 000000000
US-20200229512-A1 Vaporization device Inactive 18-Jan-2019 0000000000
GB-202111012-D0 Vaporization device Active 18-Jan-2019 000000000
GB-2595107-A Vaporization device Active 18-Jan-2019 000000000 0
US-20200229508-A1 Vaporization device Active 18-Jan-2019 A24F40/50 00
To view Hale Therapeutics’s complete patent history, request access »

Hale Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Josh Israel Co-Founder, Chief Executive Officer and Board Member
Devin Serago Co-Founder & Chief Operating Officer
Zafer Balbous Engineering Manager and Embedded Software Developer
Predrag Markovic Head of Product Design
You’re viewing 4 of 7 executive team members. Get the full list »

Hale Therapeutics Board Members (1)

Name Representing Role Since
Josh Israel Hale Therapeutics Co-Founder, Chief Executive Officer and Board Member 000 0000
To view Hale Therapeutics’s complete board members history, request access »

Hale Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hale Therapeutics Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
AlphaLab Health Accelerator/Incubator Minority 000 0000 000000 0
Atland Ventures Venture Capital Minority 000 0000 000000 0
Corrato Corrato Angel (individual) Minority 000 0000 000000 0
Feldsmith Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 28 investors. Get the full list »

Hale Therapeutics FAQs

  • When was Hale Therapeutics founded?

    Hale Therapeutics was founded in 2017.

  • Who is the founder of Hale Therapeutics?

    Josh Israel, Devin Serago, Sabrina Ko, and Jeff Domenighini are the founders of Hale Therapeutics.

  • Who is the CEO of Hale Therapeutics?

    Josh Israel is the CEO of Hale Therapeutics.

  • Where is Hale Therapeutics headquartered?

    Hale Therapeutics is headquartered in Philadelphia, PA.

  • What is the size of Hale Therapeutics?

    Hale Therapeutics has 16 total employees.

  • What industry is Hale Therapeutics in?

    Hale Therapeutics’s primary industry is Therapeutic Devices.

  • Is Hale Therapeutics a private or public company?

    Hale Therapeutics is a Private company.

  • What is Hale Therapeutics’s current revenue?

    The current revenue for Hale Therapeutics is 000000.

  • How much funding has Hale Therapeutics raised over time?

    Hale Therapeutics has raised $2.35M.

  • Who are Hale Therapeutics’s investors?

    National Institutes of Health, AlphaLab Health, Atland Ventures, Corrato Corrato, and Feldsmith Capital are 5 of 28 investors who have invested in Hale Therapeutics.

  • Who are Hale Therapeutics’s competitors?

    Pelago, Lucy (Food Products), Glaxosmithkline Consumer Healthcare, Johnson & Johnson, and Pfizer (Pharmaceuticals) are competitors of Hale Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »